Readers of this blog are, by now, aware of the many issues surrounding Merck’s blockbuster nonsteroidal, anti-inflammatory medication Vioxx (rofecoxib) and negative cardiac events. The cardiac problems associated with Vioxx, and its subsequent withdrawal from the market, spawned scores of lawsuits. These include Merck shareholder lawsuits, which were recently the subject of oral [ ]
Oregon pharmaceutical bill debated
SALEM, Ore. Democrats are criticizing a Republican-backed bill that would limit consumers' ability to sue pharmaceutical companies if drugs cause health problems. would prevent Oregonians harmed by drugs such as Vioxx and Bextra both FDA-approved medicines later pulled from
Vioxx maker suffers two setbacks in court
Merck & Co. suffered two Vioxx trial setbacks yesterday, calling into question the drugmaker's strategy of taking on litigation over the withdrawn painkiller one case at a time.
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved